Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Figure S2 from Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid Tumors
  1. Home
  2. Publications
  3. Figure S2 from Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid Tumors

Figure S2 from Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid Tumors

Authors:
  • JPJong Chul Park
    Jong Chul Park
  • DBDavid Berz
    David Berz
  • MSManish R. Sharma
    Manish R. Sharma
  • JMJyoti Malhotra
    Jyoti Malhotra
  • ATAnthony W. Tolcher
    Anthony W. Tolcher
  • RHRalph J. Hauke
    Ralph J. Hauke
  • JCJustin A. Call
    Justin A. Call
  • JHJohn T. Hamm
    John T. Hamm
  • RSRachel E. Sanborn
    Rachel E. Sanborn
  • NHNaomi B. Haas
    Naomi B. Haas
  • FTFrank Tsai
    Frank Tsai
  • DADoug R. Adkins
    Doug R. Adkins

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2767-9764.32699407
Abstract
Figure S2 shows that in vitro INBRX-105 resulted in greater T-cell modulation than a constitutive 4-1BB agonist that was provided alone or in combination with a PD-L1 antagonist
Keywords
  • CHECKPOINT BLOCKADE
  • HEAD, NECK & ORAL CANCERS
  • IMMUNOTHERAPY
  • AGONIST ANTIBODIES
  • LUNG CANCER
  • PHASE I CLINICAL TRIALS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.